{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:48:00Z","timestamp":1785361680241,"version":"3.55.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.anai.2026.04.025","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:44:59Z","timestamp":1778759099000},"page":"139-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Precision medicine in eosinophilic esophagitis"],"prefix":"10.1016","volume":"137","author":[{"given":"Caitlin M.","family":"Burk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9286-4268","authenticated-orcid":false,"given":"David A.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.anai.2026.04.025_bib0001","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1056\/NEJMra1502863","article-title":"Eosinophilic esophagitis","volume":"373","author":"Furuta","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2026.04.025_bib0002","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cgh.2024.09.031","article-title":"Prevalence and costs of eosinophilic esophagitis in the United States","volume":"23","author":"Thel","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.anai.2026.04.025_bib0003","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1016\/j.jaip.2022.09.028","article-title":"High prevalence of gastrointestinal symptoms and undiagnosed eosinophilic esophagitis among allergic adults","volume":"10","author":"Eid","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2026.04.025_bib0004","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-052889","article-title":"Differentiating eosinophilic esophagitis and eating\/feeding disorders","volume":"149","author":"Cifra","year":"2022","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.anai.2026.04.025_bib0005","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.jaip.2022.02.049","article-title":"Novel questionnaires for assessing signs and symptoms of eosinophilic esophagitis in children","volume":"10","author":"Kamat","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2026.04.025_bib0006","doi-asserted-by":"crossref","first-page":"31","DOI":"10.14309\/ajg.0000000000003194","article-title":"ACG clinical guideline: diagnosis and management of eosinophilic esophagitis","volume":"120","author":"Dellon","year":"2025","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.anai.2026.04.025_bib0007","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/cea.14215","article-title":"Food antigen consumption and disease activity affect food-specific IgG4 levels in patients with eosinophilic esophagitis (EoE)","volume":"53","author":"McGowan","year":"2023","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.anai.2026.04.025_bib0008","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41395-018-0052-5","article-title":"The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort","volume":"113","author":"Warners","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.anai.2026.04.025_bib0009","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1053\/j.gastro.2015.11.004","article-title":"Symptoms have modest accuracy in detecting endoscopic and histologic remission in adults with eosinophilic esophagitis","volume":"150","author":"Safroneeva","year":"2016","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.anai.2026.04.025_bib0010","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaip.2024.12.030","article-title":"Clinical monitoring of eosinophilic esophagitis using the esophageal string test","volume":"13","author":"Chang","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2026.04.025_bib0011","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1038\/s41467-021-26939-9","article-title":"Desmoplakin and periplakin genetically and functionally contribute to eosinophilic esophagitis","volume":"12","author":"Shoda","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.anai.2026.04.025_bib0012","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.jaci.2024.03.004","article-title":"Overlap of eosinophilic esophagitis with inborn errors of immunity and immune dysregulation","volume":"153","author":"Constantine","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2026.04.025_bib0013","article-title":"Challenging assumptions about the demographics of eosinophilic gastrointestinal diseases: a systematic review","volume":"3","author":"Chehade","year":"2024","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"5","key":"10.1016\/j.anai.2026.04.025_bib0014","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jaci.2014.07.021","article-title":"Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis","volume":"134","author":"Alexander","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2026.04.025_bib0015","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-060531","article-title":"Patterns in the development of pediatric allergy","volume":"152","author":"Gabryszewski","year":"2023","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.anai.2026.04.025_bib0016","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2500\/aap.2026.47.250081","article-title":"Risk of developing eosinophilic esophagitis with preexisting asthma, allergic rhinitis, atopic dermatitis, or food allergy","volume":"47","author":"Haber","year":"2026","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"10.1016\/j.anai.2026.04.025_bib0017","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jaip.2018.05.010","article-title":"Eosinophilic esophagitis is a late manifestation of the allergic march","volume":"6","author":"Hill","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"79","key":"10.1016\/j.anai.2026.04.025_bib0018","doi-asserted-by":"crossref","first-page":"eabp9940","DOI":"10.1126\/sciimmunol.abp9940","article-title":"Epithelial-intrinsic defects in TGFbetaR signaling drive local allergic inflammation manifesting as eosinophilic esophagitis","volume":"8","author":"Laky","year":"2023","journal-title":"Sci Immunol"},{"issue":"195","key":"10.1016\/j.anai.2026.04.025_bib0019","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006448","article-title":"TGFbeta receptor mutations impose a strong predisposition for human allergic disease","volume":"5","author":"Frischmeyer-Guerrerio","year":"2013","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.anai.2026.04.025_bib0020","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.jaci.2016.10.045","article-title":"Eosinophilic esophagitis and colonic mucosal eosinophilia in netherton syndrome","volume":"139","author":"Paluel-Marmont","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2026.04.025_bib0021","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jaci.2018.04.007","article-title":"Epithelial barrier dysfunction in desmoglein-1 deficiency","volume":"142","author":"Polivka","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2026.04.025_bib0022","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/mi.2013.90","article-title":"Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis","volume":"7","author":"Sherrill","year":"2014","journal-title":"Mucosal Immunol"},{"issue":"1","key":"10.1016\/j.anai.2026.04.025_bib0023","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaci.2020.10.018","article-title":"Replication and meta-analyses nominate numerous eosinophilic esophagitis risk genes","volume":"147","author":"Kottyan","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2026.04.025_bib0024","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jaci.2017.09.046","article-title":"Eosinophilic esophagitis (EoE) genetic susceptibility is mediated by synergistic interactions between EoE-specific and general atopic disease loci","volume":"141","author":"Martin","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2026.04.025_bib0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41435-018-0034-z","article-title":"Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitis","volume":"20","author":"Kottyan","year":"2019","journal-title":"Genes Immun"},{"issue":"3","key":"10.1016\/j.anai.2026.04.025_bib0026","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jaci.2021.08.018","article-title":"A genome-wide association meta-analysis identifies new eosinophilic esophagitis loci","volume":"149","author":"Chang","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2026.04.025_bib0027","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1038\/ncomms6593","article-title":"GWAS identifies four novel eosinophilic esophagitis loci","volume":"5","author":"Sleiman","year":"2014","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.anai.2026.04.025_bib0028","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng.547","article-title":"Common variants at 5q22 associate with pediatric eosinophilic esophagitis","volume":"42","author":"Rothenberg","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.anai.2026.04.025_bib0029","doi-asserted-by":"crossref","unstructured":"Trimarchi MP, Namjou-Khales B, Morgenstern NB, Rochman M, Chen X, Osswald G, et al. Multi-trait analysis of GWAS expands eosinophilic esophagitis genetic susceptibility and polygenic risk scores. Research Square. Accessed March 1, 2026. Available at https:\/\/www.researchsquare.com\/article\/rs-6630283\/v2","DOI":"10.21203\/rs.3.rs-6630283\/v1"},{"issue":"7","key":"10.1016\/j.anai.2026.04.025_bib0030","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.cgh.2017.12.019","article-title":"Eosinophilic esophagitis reference score accurately identifies disease activity and treatment effects in children","volume":"16","author":"Wechsler","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.anai.2026.04.025_bib0031","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaci.2024.11.002","article-title":"Implementation of the esophageal string test in clinical practice and research","volume":"155","author":"Schroeder","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2026.04.025_bib0032","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/gutjnl-2012-303171","article-title":"The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis","volume":"62","author":"Furuta","year":"2013","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.anai.2026.04.025_bib0033","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/ajg.2017.244","article-title":"Accuracy and safety of the Cytosponge for assessing histologic activity in eosinophilic esophagitis: a two-center study","volume":"112","author":"Katzka","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.anai.2026.04.025_bib0034","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/MPG.0b013e318228cee6","article-title":"Exploring potential noninvasive biomarkers in eosinophilic esophagitis in children","volume":"53","author":"Subbarao","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.anai.2026.04.025_bib0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000341421","article-title":"Elevated plasma cytokines in Japanese patients with eosinophilic esophagitis and gastroenteritis","volume":"86","author":"Kinoshita","year":"2012","journal-title":"Digestion"},{"issue":"9","key":"10.1016\/j.anai.2026.04.025_bib0036","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/apt.13386","article-title":"Peripheral blood eosinophils and other noninvasive biomarkers can monitor treatment response in eosinophilic oesophagitis","volume":"42","author":"Schlag","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.anai.2026.04.025_bib0037","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/MCG.0000000000000621","article-title":"Longitudinal evaluation of noninvasive biomarkers for eosinophilic esophagitis","volume":"51","author":"Min","year":"2017","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.anai.2026.04.025_bib0038","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/MPG.0000000000002583","article-title":"Monitoring eosinophilic esophagitis disease activity with blood eosinophil progenitor levels","volume":"70","author":"Henderson","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.anai.2026.04.025_bib0039","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jaci.2018.10.036","article-title":"Eosinophil progenitor levels correlate with tissue pathology in pediatric eosinophilic esophagitis","volume":"143","author":"Schwartz","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.anai.2026.04.025_bib0040","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1111\/all.14874","article-title":"Noninvasive biomarkers identify eosinophilic esophagitis: a prospective longitudinal study in children","volume":"76","author":"Wechsler","year":"2021","journal-title":"Allergy"},{"issue":"62","key":"10.1016\/j.anai.2026.04.025_bib0041","doi-asserted-by":"crossref","first-page":"eabi5586","DOI":"10.1126\/sciimmunol.abi5586","article-title":"Clonally expanded, GPR15-expressing pathogenic effector T(H)2 cells are associated with eosinophilic esophagitis","volume":"6","author":"Morgan","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.anai.2026.04.025_bib0042","doi-asserted-by":"crossref","unstructured":"Burk CM, Morgan DM, Glickman JN, Virkud YV, Liao E, Moseley EG, et al. GPR15 and CD38 define a subset of peripheral blood pathogenic effector Th2 cells associated with active eosinophilic esophagitis. bioRxiv. Accessed March 1, 2026. Available at: https:\/\/www.biorxiv.org\/content\/10.1101\/2025.11.16.688265v1","DOI":"10.1101\/2025.11.16.688265"},{"issue":"401","key":"10.1016\/j.anai.2026.04.025_bib0043","doi-asserted-by":"crossref","first-page":"eaam9171","DOI":"10.1126\/scitranslmed.aam9171","article-title":"A phenotypically and functionally distinct human T(H)2 cell subpopulation is associated with allergic disorders","volume":"9","author":"Wambre","year":"2017","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.anai.2026.04.025_bib0044","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.chest.2019.10.009","article-title":"Recent advances in severe asthma: from phenotypes to personalized medicine","volume":"157","author":"Schoettler","year":"2020","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.anai.2026.04.025_bib0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.anai.2019.12.011","article-title":"Phenotypes and endotypes in eosinophilic esophagitis","volume":"124","author":"Ruffner","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"10.1016\/j.anai.2026.04.025_bib0046","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S2468-1253(18)30096-7","article-title":"Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study","volume":"3","author":"Shoda","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.anai.2026.04.025_bib0047","first-page":"1","article-title":"Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring","volume":"30","author":"Collins","year":"2017","journal-title":"Dis Esophagus"},{"issue":"1","key":"10.1016\/j.anai.2026.04.025_bib0048","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2022.03.025","article-title":"A clinical severity index for eosinophilic esophagitis: development, consensus, and future directions","volume":"163","author":"Dellon","year":"2022","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.anai.2026.04.025_bib0049","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.gie.2013.10.027","article-title":"A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease","volume":"79","author":"Dellon","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"12","key":"10.1016\/j.anai.2026.04.025_bib0050","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S1542-3565(05)00885-2","article-title":"Eosinophilic esophagitis: a 10-year experience in 381 children","volume":"3","author":"Liacouras","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.anai.2026.04.025_bib0051","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s10620-018-4928-4","article-title":"Efficacy of atopy patch testing in directed dietary therapy of eosinophilic esophagitis: a pilot study","volume":"63","author":"Eckmann","year":"2018","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.anai.2026.04.025_bib0052","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/all.12846","article-title":"Eosinophilic esophagitis is characterized by a nonige-mediated food hypersensitivity","volume":"71","author":"Simon","year":"2016","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2026.04.025_bib0053","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.jaci.2012.03.023","article-title":"Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis","volume":"129","author":"Henderson","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2026.04.025_bib0054","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/j.gastro.2014.05.036","article-title":"Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE","volume":"147","author":"Clayton","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.anai.2026.04.025_bib0055","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jaip.2016.11.010","article-title":"Eosinophilic esophagitis during peanut oral immunotherapy with omalizumab","volume":"5","author":"Burk","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2026.04.025_bib0056","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S2468-1253(23)00012-2","article-title":"One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial","volume":"8","author":"Kliewer","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.anai.2026.04.025_bib0057","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jaci.2024.08.023","article-title":"One-food versus 4-food elimination diet for pediatric eosinophilic esophagitis: a multisite randomized trial","volume":"155","author":"Kliewer","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.anai.2026.04.025_bib0058","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1111\/all.14854","article-title":"Peripheral markers of allergen-specific immune activation predict clinical allergy in eosinophilic esophagitis","volume":"76","author":"Dilollo","year":"2021","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2026.04.025_bib0059","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/diagnostics16020175","article-title":"Evaluation of functional T-cell assays that predict causal allergens in eosinophilic esophagitis","volume":"16","author":"Dilollo","year":"2026","journal-title":"Diagnostics (Basel)"},{"issue":"9","key":"10.1016\/j.anai.2026.04.025_bib0060","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/j.jaip.2023.06.035","article-title":"Recent advances in the treatment of eosinophilic esophagitis","volume":"11","author":"Uchida","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.anai.2026.04.025_bib0061","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S2468-1253(23)00204-2","article-title":"Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","volume":"8","author":"Rothenberg","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.anai.2026.04.025_bib0062","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2147\/JAA.S274524","article-title":"Proton pump inhibitor therapy for eosinophilic esophagitis: history, mechanisms, efficacy, and future directions","volume":"15","author":"Franciosi","year":"2022","journal-title":"J Asthma Allergy"},{"issue":"6","key":"10.1016\/j.anai.2026.04.025_bib0063","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/cpt.2015","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2C19 and proton pump inhibitor dosing","volume":"109","author":"Lima","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.anai.2026.04.025_bib0064","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/ajg.2015.314","article-title":"Long-term loss of response in proton pump inhibitor-responsive esophageal eosinophilia is uncommon and influenced by CYP2C19 genotype and rhinoconjunctivitis","volume":"110","author":"Molina-Infante","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.anai.2026.04.025_bib0065","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/MPG.0000000000002480","article-title":"CYP2C19 and STAT6 variants influence the outcome of proton pump inhibitor therapy in pediatric eosinophilic esophagitis","volume":"69","author":"Mougey","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"10.1016\/j.anai.2026.04.025_bib0066","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/all.13432","article-title":"Association of STAT6 gene variants with food allergy diagnosed by double-blind placebo-controlled food challenges","volume":"73","author":"van Ginkel","year":"2018","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.anai.2026.04.025_bib0067","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jaci.2011.09.029","article-title":"A genome-wide association study of plasma total IgE concentrations in the Framingham Heart Study","volume":"129","author":"Granada","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2026.04.025_bib0068","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jdermsci.2015.05.006","article-title":"Association of STAT6 genetic variants with childhood atopic dermatitis in Taiwanese population","volume":"79","author":"Lee","year":"2015","journal-title":"J Dermatol Sci"},{"issue":"8","key":"10.1016\/j.anai.2026.04.025_bib0069","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.humimm.2014.06.007","article-title":"Association of STAT6 variants with asthma risk: a systematic review and meta-analysis","volume":"75","author":"Qian","year":"2014","journal-title":"Hum Immunol"},{"issue":"10","key":"10.1016\/j.anai.2026.04.025_bib0070","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.cgh.2020.08.020","article-title":"STAT6 variants associate with relapse of eosinophilic esophagitis in patients receiving long-term proton pump inhibitor therapy","volume":"19","author":"Mougey","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.anai.2026.04.025_bib0071","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/jcag\/gwaf003","article-title":"Optimizing proton-pump inhibitor therapy in paediatric eosinophilic esophagitis through CYP2C19 pharmacogenetic testing","volume":"8","author":"Scodellaro","year":"2025","journal-title":"J Can Assoc Gastroenterol"},{"issue":"10","key":"10.1016\/j.anai.2026.04.025_bib0072","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.cgh.2025.01.015","article-title":"Worsening disease severity as measured by I-SEE associates with decreased treatment response to topical steroids in eosinophilic esophagitis patients","volume":"23","author":"Reed","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.anai.2026.04.025_bib0073","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cgh.2018.09.005","article-title":"Clinical and molecular factors associated with histologic response to topical steroid treatment in patients with eosinophilic esophagitis","volume":"17","author":"Eluri","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.anai.2026.04.025_bib0074","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10620-025-09648-x","article-title":"Differences in presentation and outcomes by type and severity of food impaction symptoms in eosinophilic esophagitis","volume":"71","author":"LaFata","year":"2026","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.anai.2026.04.025_bib0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.dld.2021.10.004","article-title":"Older patients with eosinophilic esophagitis have high treatment response to topical steroids","volume":"54","author":"Ketchem","year":"2022","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.anai.2026.04.025_bib0076","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.cgh.2014.07.034","article-title":"Predictors of response to steroid therapy for eosinophilic esophagitis and treatment of steroid-refractory patients","volume":"13","author":"Wolf","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.anai.2026.04.025_bib0077","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000622","article-title":"Validation of epigenetic markers for the prediction of response to topical corticosteroid treatment in eosinophilic esophagitis","volume":"14","author":"Jensen","year":"2023","journal-title":"Clin Transl Gastroenterol"},{"issue":"3","key":"10.1016\/j.anai.2026.04.025_bib0078","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.anai.2022.12.014","article-title":"Clinical guidance for the use of dupilumab in eosinophilic esophagitis: a yardstick","volume":"130","author":"Aceves","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2026.04.025_bib0079","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/all.15966","article-title":"Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy","volume":"79","author":"Voskamp","year":"2024","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.anai.2026.04.025_bib0080","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3390\/toxins15030181","article-title":"Streptavidin-saporin: converting biotinylated materials into targeted toxins","volume":"15","author":"Ancheta","year":"2023","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.anai.2026.04.025_bib0081","doi-asserted-by":"crossref","first-page":"e1314","DOI":"10.1002\/cti2.1314","article-title":"RNA sequencing identifies global transcriptional changes in peripheral CD4(+) cells during active oesophagitis and following epicutaneous immunotherapy in eosinophilic oesophagitis","volume":"10","author":"Ruffner","year":"2021","journal-title":"Clin Transl Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626001985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626001985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T09:56:14Z","timestamp":1785318974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120626001985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1081120626001985"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2026.04.025","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision medicine in eosinophilic esophagitis","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2026.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}